Observational studyBMC cancer2022
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer.
Stefanie D Krens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it